HomeEXECUTIVESKevin L. Hagan to Serve as Next President/CEO of The PAN Foundation

Kevin L. Hagan to Serve as Next President/CEO of The PAN Foundation

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

Under the Program, the FDA will provide the Genio® system with priority review & interaction with FDA’s experts throughout the premarket review phase until the product is commercialized in the US.

FDA Will Follow The Science On COVID-19 Vaccines For Young Children

As schools around the country are re-opening for in-person learning and families are returning to their busy school year schedules, we know many parents...

FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted

As required by statute, a key consideration in their review of premarket tobacco product applications submitted for products like e-cigarettes is to determine whether permitting the marketing of the product would be "appropriate for the protection of the public health," taking into account the risks and benefits to the population as a whole.

NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode

"This represents yet another critical milestone met by the Company as we continue to execute our strategy.  The next steps for the Company are to expand the sEEG labeling for longer term use, which we believe will be a key part of our commercialization strategy for the Evo sEEG electrode, and complete development of an sEEG ablation electrode/probe for ablation of brain tissue and permanently implanted stimulation electrodes for patients with chronic applications such as epilepsy, Parkinson's disease and chronic back pain," said Dave Rosa, CEO of NeuroOne.

Asensus Surgical Receives FDA 510(k) Clearance for Expansion of Machine Vision Capabilities

Additional Intelligent Surgical Unit™ (ISU™) features will further extend augmented intelligence leadership in surgery.

EndoSound Vision Ultrasound System Receives FDA Breakthrough Device Designation

“The Breakthrough Device Designation is evidence of the transformative potential the EndoSound Vision System presents,” stated Dr. Stephen Steinberg, MD, EndoSound Founder, and President.

Kevin L. Hagan succeeds Dan Klein, who is retiring after serving at the helm for seven years. Hagan’s appointment comes after a nationwide search by executive search firm Korn Ferry on behalf of the PAN Foundation Board of Directors.

“We are proud to name Kevin Hagan as the next president and CEO of the PAN Foundation,” said Board Chair Susan Rucker. “The Board of Directors agreed that he has the experience, acumen, and commitment to lead the organization at this pivotal moment as we advance our mission of serving patients in an expanded role and advocate for healthcare access and affordability.”

Kevin L. Hagan brings significant executive leadership experience at national and global nonprofit organizations, high-impact companies in the private sector, and within government. Hagan most recently served as CEO of Thrive Impact, a consulting firm he co-founded in 2018 that supports leadership teams at nonprofits, associations, and foundations in the areas of organizational strategy, leadership and governance, and revenue diversification.

Before founding Thrive Impact, Hagan led the growth and transformation for several highly respected national and international nonprofits, previously serving as CEO of the American Diabetes Association from 2015-2017, president and CEO of Feed the Children from 2012-2015, and chief operating officer of Good360 from 2009-2012. Prior to his nonprofit service, Hagan served as head of public affairs and communications for U.S. Foods, North America’s second-largest food distributor, where he also oversaw its philanthropic work. He joined U.S. Foods after more than a decade of national-level management roles at the United States Postal Service.

“Kevin brings decades of experience as an innovative leader and champion for tackling big challenges, such as finding a cure for diabetes and ending hunger in the U.S. and abroad. He understands the impact of the healthcare affordability crisis on people experiencing serious illnesses and, importantly, is dedicated to finding solutions,” said Board Vice Chair Deanna Banks. “As president and CEO, Kevin will build on the PAN Foundation’s significant accomplishments during the last seven years and pursue initiatives that address patients’ most pressing challenges.”

“Stepping into this role is a privilege and responsibility that I do not take lightly,” said Hagan. “Today, people with serious illnesses face tremendous barriers to getting treatment, making the PAN Foundation’s role as a charitable safety net more vital than ever. Serving as president and CEO, I am committed to making our vision of a nation where everyone can get medical treatment a reality.”

As president and CEO, Hagan will lead the PAN Foundation’s strategy and oversee its safety net programs and advocacy initiatives. To date, the organization has helped nearly one million patients pay for their out-of-pocket prescription medications and built a comprehensive advocacy platform to call for critical healthcare reforms.

spot_img

DON'T MISS

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Holmes Regional Medical Center Deploys Carestream Systems to Meet a Wide Array of Diagnostic Imaging Needs

Holmes Regional Medical Center opted to outfit their R/F room with the capabilities of a fully functioning digital radiography (DR) room, as well as the standard features of a conventional R/F room, by installing a CARESTREAM DRX-Ascend system with an overhead tube in conjunction with the DRX-Excel Plus.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy